Science Collected

🔥Module 2 is available! Continue our series of interactive e-learning modules that guide you in the diagnosis and management of #CKD patients. 🎯Module 2 focuses on the critical steps of diagnosing and initiating treatment of CKD. Start Module 2👉 bit.ly/41kDZAk

Gain valuable knowledge on managing #hyperkalaemia in cardiorenal patients. Watch the recorded symposium here 👉bit.ly/47nWZ2G #CardiorenalDisease #CKD #MedicalEducation

🚨 Attention! We want to hear from you. At Science Collected, we value your input to shape our educational offerings. How do you prefer to learn? Share your insights. Have a new idea or suggestion? Leave a comment! We are all ears. #MedTwitter #MedEd

🎙️2 podcasts, 1 goal: Answers in 6 minutes. 3 critical steps in 3 months to save #CKD lives. How? eGFR dip and #SGLT2 inhibitors — any concern? Explore 2 podcasts with Prof. David Cherney & @kieranmccaffs on kidney care & SGLT2 inhibitors. 🎧Listen 👉 bit.ly/3QBkChy

📊 Explore our insightful infographic on SGLT2 inhibitors' role in #hypertension, #CKD, #HF & #T2D management based on the latest #ESH2023 guidelines. 🔗 Attached here 👉 bit.ly/3ugURLV

🔥Module 1 is out! Our 3 interactive e-learning modules guide you through the steps from the diagnosis and management of the #CKD patients. 🎯 Module 1 covers the steps to take for screening a patient with a risk of CKD. Start now 👉 bit.ly/3NqAy5x #MedEd

🔥Exciting news! Our expert-led educational presentations are now available! 📚Visualise your learning with engaging visuals and key points. 🔎Discover a goldmine of knowledge in #renal , #cardiovasvular, #rare and #metabolic diseases. 👉bit.ly/47xG8uh

Nephrologists provide vital cardiorenal protection to #CKD patients, while primary care physicians play a key role in early CKD detection. The common goal: Better #patient outcomes. Curious about this collaboration in CKD care? Watch👉bit.ly/3sv6LBj #nephwitter

26/ You’ve reached the end of this tweetorial! 🙌 You can view the full #DUKPC2023 symposium recording on the @ScienceCollect1 educational platform at science-collected.com/education/. We also encourage you to catch our #podcast series. See you there!

25/ CV health should be at the forefront of #T2D management. Residual #CVD risk remains high for people with T2D despite current #lipid-lowering therapies. #Omega3 fatty acid research may lead to T2D therapy evolution using a holistic cardiorenal-metabolic approach.

1/ Welcome to the official tweetorial for ‘Optimising lipid control in diabetes – the rise of omega-3 fatty acids’! We’ll recap the key messages from this #DUKPC symposium featuring @drsarahjdavies, @drnkan and Dr Handrean Soran. #T2D #lipid #CVD #DUKPC2023